{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:50:59Z","timestamp":1783993859709,"version":"3.55.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1111\/j.1567-1364.2006.00128.x","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T07:00:02Z","timestamp":1152169202000},"page":"152-164","source":"Crossref","is-referenced-by-count":31,"title":["Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil"],"prefix":"10.1093","volume":"7","author":[{"given":"Ana Marisa Fusco","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Teruyuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Cristiane","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana Bellan","family":"De Oliveira e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Aparecida Pizzirani","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00c3\u00a1rcia de Souza Carvalho","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00c3\u00a9 Soares","family":"Mendes Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Laboratory Group on Cryptococcosis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB1|cit1","unstructured":"Almeida AMF 2000 Cryptococcus neoformans"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0732-8893(95)00169-7","article-title":"Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients","volume":"23","author":"Barchiesi","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1128\/JCM.42.3.1356-1359.2004","article-title":"Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil","volume":"42","author":"Barreto de Oliveira","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/517056","article-title":"The hidden danger of primary fluconazole prophylaxis in patients with acquired immunodeficiency syndrome","volume":"26","author":"Berg","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1099\/00207713-47-2-432","article-title":"Molecular typing of Cryptococcus neoformans, taxonomic and epidemiological aspects","volume":"47","author":"Boekhout","year":"1997","journal-title":"Int J Syst Bacteriol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB6|cit6","first-page":"31","article-title":"Destaque para as infec\u00c3\u00a7\u00c3\u00b5es f\u00c3\u00bangicas em pacientes com Aids e no hospedeiro imunocomprometido no Brasil","volume":"1","author":"Branchini","year":"2000","journal-title":"J Bras AIDS"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/JCM.34.4.912-917.1996","article-title":"Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States","volume":"34","author":"Brandt","year":"1996a","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/infdis\/174.4.812","article-title":"Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis","volume":"174","author":"Brandt","year":"1996b","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.45.11.3065-3069.2001","article-title":"Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992\u00e2\u0080\u00931994 and 1996\u00e2\u0080\u00931998","volume":"45","author":"Brandt","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/JCM.39.6.2348-2350.2001","article-title":"Antifungal susceptibilities, varieties and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brasil, Chile, and Venezuela","volume":"39","author":"Calvo","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/9781555818241.ch11","volume-title":"Cryptococcus neoformans","author":"Casadevall","year":"1998"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1567-1356(03)00038-2","article-title":"Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul","volume":"3","author":"Casali","year":"2003","journal-title":"FEMS Yeast Res"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.33.3.535-540.1995","article-title":"Comparison of E-test and National Committee for Clinical Laboratory Standards broth macrodiluition method for azole antifungal susceptibility testing","volume":"33","author":"Colombo","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB14|cit14","first-page":"133","article-title":"Should antifungal treatments be based upon results of antifungal susceptibility testing?","volume":"19","author":"Cuenca-Estrella","year":"2002","journal-title":"Rev Iberoam Micol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00019048-199507000-00019","article-title":"Decreased fluconazole susceptibility of a relapse Cryptococcus neoformans isolate after fluconazole treatment","volume":"4","author":"Currie","year":"1995","journal-title":"Infect Dis Clin Pract"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB16|cit16","first-page":"7","article-title":"Human cryptococcosis","volume":"159","author":"Delgado","year":"2005","journal-title":"relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/AAC.40.3.822","article-title":"In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs","volume":"40","author":"Franzot","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB18|cit18","first-page":"2243","article-title":"Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States","volume":"35","author":"Franzot","year":"1997","journal-title":"evidence for both local genetic differences and a global clonal population structure"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/IAI.66.1.89-97.1998","article-title":"Microevolution of a standard of Cryptococcus neoformans resulting in differences in virulence and other phenotypes","volume":"66","author":"Franzot","year":"1998","journal-title":"Infect Immun"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/314521","article-title":"Serial isolates of Cryptococcusneoformans from patients with AIDS differ in virulence for mice","volume":"178","author":"Fries","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/JCM.34.6.1531-1534.1996","article-title":"Karyotype instability in Cryptococcus neoformans infection","volume":"34","author":"Fries","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1097\/00002030-200111230-00026","article-title":"Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease","volume":"15","author":"Friese","year":"2001","journal-title":"AIDS"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/714031150","article-title":"Epidemiological aspects of clinical and environmental Cryptocococcus neoformans isolates in the Brazilian state Rio Grande do Sul","volume":"40","author":"Horta","year":"2002","journal-title":"Med Mycol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/13693780310001644743","article-title":"Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro","volume":"42","author":"Igreja","year":"2004","journal-title":"Med Mycol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1128\/JCM.43.11.5733-5742.2005","article-title":"Molecular epidemiology of clinical Cryptococcus neoformans strains from India","volume":"43","author":"Jain","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.36.12.3653-3656.1998","article-title":"Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987\u00e2\u0080\u00931994","volume":"36","author":"Klepser","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/IAI.60.5.1869-1874.1992","article-title":"Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii","volume":"60","author":"Kwon-Chung","year":"1992","journal-title":"Infect Immun"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(92)90628-3","article-title":"Isolation, characterization, and sequencing of Candida albicans repetitive element 2","volume":"116","author":"Lasker","year":"1992","journal-title":"Gene"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/714030957","article-title":"Possible primary ecological niche of Cryptococcus neoformans","volume":"38","author":"Lazera","year":"2000","journal-title":"Med Mycol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB30|cit30","first-page":"28","article-title":"Infection due to fluconazole-resistant Candida in patients with AIDS","volume":"24","author":"Maenza","year":"1997","journal-title":"prevalence and microbiology"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","article-title":"Molecular typing of IberoAmerican Cryptococcus neoformans isolates","volume":"9","author":"Meyer","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB32|cit32","unstructured":"Minist\u00c3\u00a9rio da Sa\u00c3\u00bade do Brasil 2002"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS \u00e2\u0080\u0093 100 years after the discovery of Cryptococcus neoformans","volume":"8","author":"Mitchell","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.43.8.1856","article-title":"Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans","volume":"43","author":"Mondon","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB35|cit35","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard M27-A","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"1997"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB36|cit36","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard. NCCLS document M27-A2","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2002"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.42.2.471","article-title":"In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and resistance Cryptococcus neoformans isolates","volume":"42","author":"Nguyen","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB39|cit38","volume-title":"Criptococose em Aids: estudo cl\u00c3\u00adnico e microbiol\u00c3\u00b3gico em 35 pacientes acompanhados no Instituto de Infectologia Em\u00c3\u00adlio Ribas, S\u00c3\u00a3o Paulo, entre 1995 a 1997","author":"Pappalardo","year":"2002"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB38|cit39","first-page":"299","article-title":"Cryptococcosis","volume":"45","author":"Pappalardo","year":"2003","journal-title":"a review of the Brazilian experience for the disease"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1054\/drup.1999.0090","article-title":"Drug resistance in Cryptococcus neoformans","volume":"2","author":"Perfect","year":"1999","journal-title":"Drug Resist Updat"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jac\/dki393","article-title":"Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans","volume":"56","author":"Perkins","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB43|cit42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0732-8893(98)00095-9","article-title":"Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients","volume":"32","author":"Pfaller","year":"1998","journal-title":"Diagn Microb Infect Dis"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB42|cit43","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Powderly","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB45|cit45","volume-title":"Aspectos fenot\u00c3\u00adpicos e moleculares de amostras de Cryptococcus neoformans da regi\u00c3\u00a3o de Araraquara e Ribeir\u00c3\u00a3o Preto, relacionados aos perfis de suscetibilidade","author":"Rezende","year":"2002"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","article-title":"G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate","volume":"47","author":"Rodero","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/AAC.40.9.1998","article-title":"Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans","volume":"40","author":"Rodriguez-Tudela","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/clinids\/18.3.369","article-title":"Clinical epidemiological study of 171 cases of cryptococcosis","volume":"18","author":"Rozenbaum","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/JCM.34.5.1280-1282.1996","article-title":"Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole","volume":"34","author":"Sanati","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","article-title":"Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002","volume":"54","author":"Sar","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/CMR.13.2.332","article-title":"The ins and outs of DNA fingerprinting the infectious fungi","volume":"13","author":"Soll","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1567-1364.2006.00128.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1128\/JCM.39.6.2060-2064.2001","article-title":"Phenotypic switching and genetic diversity of Cryptococcusneoformans","volume":"39","author":"Sukroongreung","year":"2001","journal-title":"J Clin Microbiol"}],"container-title":["FEMS Yeast Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsyr\/article-pdf\/7\/1\/152\/18017389\/7-1-152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T02:30:42Z","timestamp":1587004242000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsyr\/article-lookup\/doi\/10.1111\/j.1567-1364.2006.00128.x"}},"subtitle":["Molecular typing and antifungal susceptibility of C. neoformans"],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":52,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1111\/j.1567-1364.2006.00128.x","relation":{},"ISSN":["1567-1356","1567-1364"],"issn-type":[{"value":"1567-1356","type":"print"},{"value":"1567-1364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}